NCT01169259 2025-11-06
VITAL
Brigham and Women's Hospital
Phase 3 Active not recruiting
Clinical Trials
7 trialsNCT01646437 2021-09-16
TIPS-3
Population Health Research Institute
Phase 3 Completed
NCT00773747 2021-04-30
Study of Vorinostat (MK-0683) or Placebo, in Combination With Bortezomib in Participants With Multiple Myeloma (MK-0683-088 AMN)
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT00000611 2016-04-15
Women's Health Initiative (WHI)
National Heart, Lung, and Blood Institute (NHLBI)
Phase 3 Completed
NCT00046306 2013-01-14
Nevada Environmental Tobacco Smoke and Health Study
National Institute of Environmental Health Sciences (NIEHS)
Phase 3 Completed
NCT00000479 2012-06-15
WHS
Brigham and Women's Hospital
Phase 3 Completed
NCT00190593 2007-01-26
Raloxifene Use for The Heart
Eli Lilly and Company
Phase 3 Completed